EvoEndo gets AGA investment for unsedated transnasal endoscopy platforms
EvoEndo has landed an investment from GI Opportunity Fund 1, a new venture capital fund of the American Gastroenterological Association (AGA) for its unsedated transnasal endoscopy platforms. Further details of the investment have not been disclosed by the US-based medical device company. Founded in 2017, EvoEndo develops sterile single-use, flexible unsedated transnasal endoscopes for assessing […]